Myval Transcatheter Heart Valve System in the Treatment of Severe Symptomatic Aortic Stenosis

Abstract

The transcatheter aortic valve replacement (TAVR) is an established treatment for patients with severe symptomatic aortic stenosis (AS) at prohibitive risk for surgery. It is an alternative treatment to surgical aortic valve replacement in patients with AS at intermediate- and high-surgical risk. Although regulatory authorities extend the indications of TAVR to treat patients at low-surgical risk, the limitations of earlier-generation transcatheter heart valve (THV) systems accelerate the development of improved newer generation of THV systems. Myval™ THV (Meril Life Sciences Pvt. Ltd., Vapi, Gujarat, India) is a newer-generation, balloon-expandable TAVR system with features that facilitate accurate positioning of the bioprosthetic valve and favorable procedural and clinical outcomes. This review summarizes existing preclinical and clinical data on Myval THV for the intervention of symptomatic native AS and lays out the plan for future research program.

Keywords:

• balloon-expandable THV
• severe symptomatic native aortic stenosis
• surgical risk
• transcatheter aortic valve replacement
• transcatheter heart valve systems

Author contributions

SK Sharma, RS Rao, M Chopra, A Sonawane, J Jose and G Sengottuvelu were responsible for the conceptualization, writing, reviewing and editing of the article.

Financial & competing interests disclosure

SK Sharma is an external scientific advisor to Meril Life Sciences Pvt. Ltd., Vapi, Gujarat, India. RS Rao, M Chopra, A Sonawane, J Jose and G Sengottuvelu are the proctors for Myval THV Technology. All the authors have received honoraria from Meril Life Sciences Pvt. Ltd., Vapi, Gujarat, India. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.